| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 323 | 389 | 406 | 452 | 398 | 299 | 393 | 376 | 348 | 367 | 463 | 534 | 458 | 465 | 507 | 501 | 375 | 558 | 541 | 538 | 387 | 432 | 439 | 513 | 404 | 451 | 443 | 551 | 372 | 318 |
| Expenses | 265 | 320 | 333 | 374 | 335 | 278 | 328 | 308 | 300 | 302 | 372 | 423 | 361 | 378 | 422 | 441 | 356 | 489 | 466 | 457 | 338 | 377 | 383 | 420 | 349 | 378 | 376 | 429 | 355 | 311 |
| EBITDA | 58 | 70 | 73 | 78 | 63 | 21 | 65 | 68 | 48 | 65 | 91 | 111 | 97 | 87 | 86 | 60 | 19 | 69 | 75 | 81 | 49 | 55 | 56 | 94 | 56 | 73 | 67 | 122 | 17 | 7 |
| Operating Profit % | 18 % | 18 % | 18 % | 17 % | 16 % | 7 % | 16 % | 18 % | 14 % | 18 % | 19 % | 20 % | 21 % | 18 % | 17 % | 12 % | 4 % | 12 % | 14 % | 15 % | 13 % | 12 % | 13 % | 18 % | 14 % | 16 % | 14 % | 22 % | 4 % | 2 % |
| Depreciation | 23 | 24 | 24 | 23 | 20 | 21 | 21 | 21 | 21 | 21 | 22 | 22 | 23 | 24 | 25 | 24 | 27 | 27 | 28 | 27 | 28 | 29 | 29 | 32 | 32 | 32 | 33 | 38 | 39 | 41 |
| Interest | 16 | 16 | 13 | 13 | 12 | 14 | 13 | 14 | 10 | 9 | 8 | 10 | 8 | 8 | 7 | 8 | 11 | 11 | 13 | 13 | 14 | 13 | 14 | 15 | 20 | 19 | 19 | 18 | 17 | 15 |
| Profit Before Tax | 23 | 36 | 42 | 48 | 37 | 10 | 42 | 38 | 23 | 41 | 62 | 81 | 68 | 60 | 62 | 29 | -12 | 33 | 36 | 49 | 10 | 17 | 22 | 47 | 7 | 25 | 24 | 68 | -30 | -47 |
| Tax | 8 | 11 | 13 | 15 | 12 | 3 | 14 | 13 | 8 | 14 | 22 | 30 | 18 | 16 | 16 | 8 | -3 | 8 | 9 | 13 | 3 | 4 | 6 | 13 | 2 | 7 | 7 | 18 | -8 | -12 |
| Net Profit | 16 | 24 | 29 | 33 | 25 | 6 | 28 | 25 | 15 | 27 | 40 | 51 | 51 | 44 | 45 | 21 | -9 | 25 | 26 | 36 | 7 | 13 | 16 | 34 | 5 | 18 | 17 | 50 | -22 | -35 |
| EPS in ₹ | 1.29 | 1.98 | 2.38 | 2.70 | 2.05 | 0.52 | 2.30 | 1.98 | 1.22 | 2.19 | 3.27 | 4.13 | 4.10 | 3.57 | 3.67 | 1.68 | -0.72 | 2.01 | 2.14 | 2.92 | 0.56 | 1.02 | 1.31 | 2.76 | 0.41 | 1.48 | 1.39 | 4.07 | -1.82 | -2.83 |
Hikal
Hikal
240.37
+1.99
(0.83%)
Key Fundamentals
Market Cap
2,939.20 Cr
EPS
7.36
PE Ratio
46.82
Dividend Yield
0.33 %
Industry
Healthcare 52 Week High
464.75
52 Week Low
229.10
PB Ratio
2.35
Debt to Equity
0.65
Sector
Pharmaceuticals Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
Hikal Limited posted a standalone net loss of Rs 341 million for the quarter ended September 30, 2025, after reversing Rs 807 million in revenue due to incomplete performance obligations. The company faces ongoing challenges from US FDA warning letter impact on pharma sales and pending Supreme Court case regarding environmental compliance with Rs 174.5 million compensation claim.
Hikal Targets 18-20% CAGR Growth Through Pharma and Crop Protection Expansion3 hours ago
Hikal announced plans for capacity expansion at its Panoli and Mahad units, targeting 18-20% CAGR over 3 years driven by pharma and crop protection segments. The company is focusing on API backward integration, long-term CDMO contracts, and strategic partnerships with global innovators to diversify its product portfolio.
Hikal Limited reported quarterly revenue of Rs 319 crore but posted a loss of Rs 35 crore, primarily due to pharmaceutical sales deferrals following USFDA audit observations and warning letter received in February 2025. The company expects strong recovery in Q3 and Q4 with improved demand visibility and higher capacity utilization as supply resumption progresses and new product commercialization advances.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,737.40 | #1 4,15,588.80 | 39.72 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 67.39 | |
6,593.50 | 1,73,085.50 | 70.39 | 9,712.00 | 18.67 | 2,191 | 35.10 | 54.08 | |
3,826.10 | 1,29,441.80 | 60.50 | 11,539.40 | 6.99 | 1,911 | 30.46 | 70.60 | |
1,525.80 | 1,22,722.10 | 22.68 | 28,409.50 | 7.12 | 5,291 | 3.71 | 46.29 | |
1,234.90 | 1,02,624.10 | #1 17.96 | 33,741.20 | 16.73 | 5,725 | -0.38 | 49.14 | |
944.15 | 95,733.10 | 18.89 | 23,511.00 | 18.55 | 4,615 | 34.60 | 37.31 | |
2,257.00 | 93,696.20 | 52.49 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 31.42 | |
2,052.90 | 92,899.30 | 21.57 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 65.31 | |
5,725.50 | 68,959.10 | 28.39 | 13,458.30 | 3.70 | 2,216 | 10.98 | 64.92 | |
1,210.20 | 68,743.70 | 20.71 | 32,345.60 | 9.43 | 3,484 | 3.81 | 71.52 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
4.35 %
Net Income Growth
30.46 %
Cash Flow Change
50.19 %
ROE
22.70 %
ROCE
30.30 %
EBITDA Margin (Avg.)
18.57 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,292 | 1,275 | 1,380 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,386 | 2,487 | 2,529 |
| Fixed Assets | 639 | 623 | 668 | 634 | 713 | 735 | 713 | 880 | 948 | 1,071 | 1,365 |
| Current Assets | 501 | 467 | 577 | 690 | 830 | 775 | 879 | 964 | 939 | 967 | 995 |
| Capital Work in Progress | 62 | 66 | 63 | 118 | 79 | 161 | 254 | 295 | 412 | 414 | 121 |
| Investments | 0 | 0 | 4 | 3 | 1 | 1 | 1 | 11 | 5 | 5 | 10 |
| Other Assets | 591 | 586 | 645 | 788 | 893 | 871 | 946 | 1,028 | 1,020 | 997 | 1,034 |
| Total Liabilities | 1,292 | 1,275 | 1,380 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,386 | 2,487 | 2,529 |
| Current Liabilities | 518 | 374 | 440 | 560 | 603 | 596 | 657 | 769 | 662 | 757 | 790 |
| Non Current Liabilities | 242 | 337 | 334 | 312 | 327 | 355 | 323 | 376 | 591 | 543 | 477 |
| Total Equity | 533 | 564 | 605 | 669 | 756 | 817 | 933 | 1,068 | 1,134 | 1,188 | 1,262 |
| Reserve & Surplus | 516 | 547 | 589 | 653 | 732 | 792 | 909 | 1,043 | 1,109 | 1,163 | 1,238 |
| Share Capital | 16 | 16 | 16 | 16 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -10 | -2 | -2 | 4 | 6 | 20 | -24 | 4 | 15 | -14 | 0 |
| Investing Activities | -43 | -64 | -102 | -110 | -125 | -164 | -156 | -284 | -292 | -174 | -137 |
| Operating Activities | 102 | 186 | 164 | 139 | 186 | 285 | 229 | 294 | 315 | 187 | 280 |
| Financing Activities | -69 | -124 | -63 | -25 | -55 | -101 | -97 | -6 | -8 | -27 | -144 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.77 % | 68.83 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % | 68.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 4.81 % | 6.13 % | 6.55 % | 6.67 % | 6.78 % | 6.06 % | 5.69 % | 5.36 % | 4.23 % |
| DIIs | 0.57 % | 0.62 % | 0.50 % | 0.35 % | 0.88 % | 0.89 % | 1.22 % | 1.57 % | 2.19 % | 2.78 % | 3.12 % | 3.15 % | 3.53 % | 3.17 % | 3.58 % | 3.48 % | 3.80 % | 4.02 % | 5.16 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 20.01 % | 19.69 % | 18.74 % | 18.50 % | 18.06 % | 18.53 % | 19.21 % | 18.78 % | 18.72 % | 18.57 % | 18.19 % | 17.02 % | 16.45 % | 16.31 % | 15.81 % | 16.64 % | 16.57 % | 16.75 % | 16.66 % |
| Others | 10.65 % | 10.93 % | 11.99 % | 12.38 % | 12.29 % | 11.81 % | 10.80 % | 10.83 % | 10.25 % | 9.80 % | 5.03 % | 4.85 % | 4.62 % | 5.01 % | 4.99 % | 4.97 % | 5.08 % | 5.02 % | 5.10 % |
| No of Share Holders | 53,021 | 61,870 | 68,233 | 72,450 | 75,341 | 79,105 | 78,500 | 75,780 | 75,167 | 75,110 | 76,126 | 74,657 | 71,840 | 70,978 | 71,912 | 71,801 | 68,907 | 71,391 | 73,404 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1.2 | 1.2 | 1.2 | 1.2 | 2 | 1.6 | 1.2 | 1.2 | 0.8 |
| Dividend Yield (%) | 0.00 | 0.87 | 0.69 | 1.72 | 0.84 | 0.5 | 0.57 | 0.45 | 0.3 | 0.34 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Nov 2025 |  Quarterly Result Announcement | NA | 13 Nov 2025 | 240.20 | 238.38 |
| 25 Jun 2018 |  Bonus | 1:2 | 22 Jun 2018 | 156.67 | 157.05 |
| 16 Feb 2021 |  Dividend | ₹ 1.00 /share | 15 Feb 2021 | 178.70 | 167.05 |
| 26 Aug 2021 | Dividend | ₹ 1.00 /share | 25 Aug 2021 | 313.95 | 626.35 |
| 24 Feb 2022 | Dividend | ₹ 1.20 /share | 23 Feb 2022 | 425.10 | 375.95 |
| 15 Sept 2022 | Dividend | ₹ 0.40 /share | 14 Sept 2022 | 381.40 | 371.95 |
| 14 Feb 2023 | Dividend | ₹ 0.60 /share | 14 Feb 2023 | 350.60 | 329.40 |
| 19 Sept 2023 | Dividend | ₹ 0.60 /share | 18 Sept 2023 | 284.00 | 309.55 |
| 20 Feb 2024 | Dividend | ₹ 0.60 /share | 20 Feb 2024 | 297.65 | 289.80 |
| 04 Sept 2024 | Dividend | ₹ 0.60 /share | 04 Sept 2024 | 293.05 | 329.15 |
| 17 Sept 2024 |  Annual General Meeting | NA | 17 Sept 2024 | 327.20 | 384.00 |
| 12 Nov 2024 | Quarterly Result Announcement | NA | 12 Nov 2024 | 370.10 | 376.55 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 338.10 | 358.80 |
| 08 Feb 2025 | Dividend | ₹ 0.60 /share | 07 Feb 2025 | 358.80 | 376.90 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 397.75 | 407.60 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 329.80 | 307.35 |
| 02 Sept 2025 | Dividend | ₹ 0.80 /share | 02 Sept 2025 | 407.60 | 256.30 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 307.35 | 262.90 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
6 hours ago
6 hours agoSubmission Of Unaudited Standalone And Consolidated Financial Results For The Quarter And The Half Year Ended September 30 20259 hours ago
9 hours agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release9 hours ago
9 hours agoAnnouncement under Regulation 30 (LODR)-Investor Presentation9 hours ago
9 hours agoBoard Meeting Outcome for Outcome Of Board Meeting9 hours ago
9 hours agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
3 days agoIntimation Of Cancellation Of Earnings Group Conference Call7 days ago
7 days agoBoard Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 20258 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Oct 31, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025Oct 31, 2025
Oct 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsOct 07, 2025
Oct 07, 2025Newspaper Advertisement Regarding Saksham Niveshak For Updating KYC And Re-Lodgment Of Transfer Requests Of Physical SharesOct 07, 2025
Oct 07, 2025Change Of Email Address Of The Registrar And Share Transfer Agent (RTA) Of The CompanyOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorOct 01, 2025
Oct 01, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationSep 26, 2025
Sep 26, 2025Voting Results Under Regulation 44 Of The SEBI Listing RegulationsSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationSep 23, 2025
Sep 23, 2025Submission Of Copy Of The Letter Sent To Shareholders To Access The Integrated Annual Report 2024-25Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2025
Aug 27, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 26, 2025
Aug 26, 2025Notice Of 37Th Annual General Meeting Of The CompanyAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 21, 2025
Aug 21, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 07, 2025
Aug 07, 2025Intimation Of 37Th Annual General Meeting Book Closure And Record DateAug 07, 2025
Aug 07, 2025Intimation Of 37Th Annual General Meeting Book Closure And Record DateAug 07, 2025
Aug 07, 2025Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Jul 31, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2025
Jul 23, 2025Disclosure under Regulation 30A of LODRJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Disclosure Under Regulation 30 SEBI Listing RegulationJun 16, 2025
Jun 16, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth | 0.84% | 1177975 | 0.40% | 0.55% | |
 Kotak Healthcare Fund Direct - Growth | 0.00% | -130000 | -0.70% | -1.04% | |
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 0.11% | 1402 | -0.01% | -0.02% | |
 Groww Nifty Total Market Index Fund Direct - Growth | 0.00% | 5 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.07% | 3 | 0.00% | 0.00% | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 0.00% | 2 | 0.00% | 0.00% | |
| Bandhan Nifty Total Market Index Fund Direct-Growth | 0.00% | -2 | 0.00% | 0.00% | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 0.00% | 2 | 0.00% | 0.00% | |
 Samco Multi Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.10% | |
 Tata India Pharma & Healthcare Fund Direct-Growth | 0.71% | 0 | -0.05% | -0.06% | |
| Tata Small Cap Fund Direct - Growth | 0.67% | 0 | -0.04% | -0.07% |
Technical Indicators
RSI(14)
Neutral 43.57
ATR(14)
Volatile 6.03
STOCH(9,6)
Neutral 23.67
STOCH RSI(14)
Neutral 34.44
MACD(12,26)
Bullish 0.21
ADX(14)
Weak Trend 19.41
UO(9)
Bearish 45.49
ROC(12)
Downtrend And Accelerating -1.90
WillR(14)
Neutral -48.16
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
